ImmunityBio, Inc. (IBRX) Stock Price & Analysis
Market: NASDAQ • Sector: Healthcare • Industry: Biotechnology
ImmunityBio, Inc. (IBRX) Profile & Business Summary
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.
Key Information
| Ticker | IBRX |
|---|---|
| Leadership | Richard Gerald Adcock |
| Exchange | NASDAQ |
| Official Site | https://immunitybio.com |
Market Trend Overview for IBRX
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
This model looks at how prices behave over time to describe the current market environment. It focuses on whether price is moving steadily, stalling, or losing momentum, and checks both short-term and weekly trends for confirmation. The goal is not to predict exact prices, but to help understand when conditions are supportive, risky, or unclear.
Current Market Context (Short-Term)
As of 2026-02-06 (ET), IBRX is moving sideways. Price at 6.05 is moving between support near 5.10 and resistance near 6.75. There is no clear direction right now. View Support & Resistance from Options
Why the market looks this way?
Prices have moved back and forth over recent sessions without making steady progress. Trend signals have changed frequently, which suggests the market is stuck in a range. In this environment, chasing moves in either direction is less reliable.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-02-06 (ET)
As of 2026-02-06, IBRX is moving sideways without a clear direction. Over the longer term, the trend remains bullish.
IBRX last closed at 6.05. The price is about 0.6 ATR below its recent average price (6.18), and the market is currently in a sideways market without a clear direction.
The market is moving sideways, with no clear direction. Both upside and downside risks remain in play.
Trend score: 35 out of 100. Overall alignment is unclear. The market is currently in a sideways market without a clear direction. The longer-term trend is still positive, but short-term signals are not yet confirming it.
A key downside level is near 3.21. If price falls below this area, the current upward trend would likely weaken or break.
On 2026-01-23, trend conditions deteriorated, suggesting that moves in the prior direction became less dependable.
[2026-01-27] Trading activity picked up, but price progress remained limited.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
Closing activity showed limited conviction and did not suggest strong overnight positioning.
Short Interest & Covering Risk for IBRX
This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.
Shows how likely a short squeeze may be under current market conditions.
Short Exposure Percentile
Short interest is at a very high historical level. If price moves against shorts, reactions could be sharp and volatile. (Historical percentile: 91%)
Structure Analysis
IBRX Short positioning is starting to look crowded. Current days to cover is 5.6 trading days, meaning short positions could unwind at a normal pace. Short covering is likely to have a normal impact on price moves.
Bull Trap Structural Risk
Risk conditions are elevated. Recent price strength may be less stable if selling pressure increases.This indicator is intended as a risk filter, not a directional signal. A High or Extreme reading does not predict an immediate move, but suggests that if prices weaken, downside reactions may be more pronounced.
Elevated short crowding (short interest as a share of float is above normal). In the latest reporting period, short interest continues to increase. As a result, similar news or market events could lead to price moves about 1× larger than usual.
Note:
Short interest data is reported every two weeks by
FINRA.
The most recent snapshot is
2026-01-15 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.